title: The alpha-synuclein mutation E46K promotes aggregation in cultured cells.
abstract: Parkinson's disease (PD) is characterized by the polymerization of wild-type (WT) or mutant alpha-synuclein (AS) into aggregates and fibrils, which are observed as Lewy bodies (LBs) and Lewy neurites (LNs) in PD patients. However, inability to demonstrate aggregation in many cell culture systems is a major drawback for effective in vitro modeling of AS aggregation. Utilizing PCR-based cloning approach, we generated A30P, A53T, and the recently reported E46K encoding mutation in the KTKEGV repeat region of AS gene. While cloning E46K mutant, a glycine deletion mutation (E46KDeltaG) adjacent to the intended lysine mutation was serendipitously generated. Expression of mutant constructs and green fluorescent protein (GFP)-tagged mutant constructs in catecholaminergic SH-SY5Y (5Y) cells revealed 40% of AS-E46KDeltaG and 18% of AS-E46K transfected cells formed aggregates as compared to 12% in AS-A53T, 6% in AS-WT, and 2% in AS-A30P transfected cells. Western blot analysis demonstrated the formation of high molecular weight AS aggregates. Electron microscopic analysis of 5Y cells expressing the E46K and E46KDeltaG mutants demonstrated two distinct kinds of inclusions: Type I, which showed dense granular profile; and Type II, which were largely membranous vacuolar inclusions without granular material. These two inclusions are reminiscent of Lewy bodies and pale bodies observed in PD postmortem brain samples. Our results demonstrate that mutations in 4th KTKEGV repeat lead to higher propensity of aggregation of AS compared to other mutants.
authors.affiliation: Department of Neurology, Washington University School of Medicine, St. Louis, MO 63108, USA.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Pandey
authors.forename: Robert E
authors.initials: RE
authors.lastname: Schmidt
authors.forename: James E
authors.initials: JE
authors.lastname: Galvin
mesh_terms: D015153:Blotting, Western / Q000379:methods; D002449:Cell Aggregation / Q000235:genetics*; D045744:Cell Line, Tumor; D005455:Fluorescent Antibody Technique / Q000379:methods; D018698:Glutamic Acid / Q000235:genetics*; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006801:Humans; D008239:Lysine / Q000235:genetics*; D046529:Microscopy, Electron, Transmission / Q000379:methods; D016296:Mutagenesis / Q000502:physiology; D009154:Mutation; D009447:Neuroblastoma / Q000648:ultrastructure; D014162:Transfection / Q000379:methods; D051844:alpha-Synuclein / Q000235:genetics*
chemical_list: D051844:alpha-Synuclein; D049452:Green Fluorescent Proteins; D018698:Glutamic Acid; D008239:Lysine